
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPTEJ6RUFxMVhiTmJIcDZ5NVhCOWpLd3EtR0FyNmhQNkZwOTdRM243SmxJVm8wSEx5VzQwSUR1bHRZTnF2aVE2R3UyTEVZWHJEdTRKUzl0UmY1Q2U5ejd6R2NwdzM1Qzg5U0VLbzBIQnlWeHh6eEw4eXVUNFY3cmxqMlVMYlpnWXJGOUU3OUt5RnJIY1d5emc?oc=5" target="_blank">Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial</a>&nbsp;&nbsp;<font color="#6f6f6f">BioPharma Dive</font>